Industry News
Relief, NeuroRx enrolls 150 patients in phase 2b/3 trial of RLF-100 for critical COVID-19 with respiratory failure
Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported
News & Articles
25